Improving HIV prevention for drug users on probation in Eastern Europe
Official title: Innovations in Implementing Medications for Opioid Use Disorder for HIV Prevention in Probation Settings in Eastern Europe
Funded at Yale University · NIH-11085528 · Data updated 2026-11-12
This study is looking for better ways to help people on probation in Eastern Europe who use drugs stay healthy and prevent HIV, by understanding their needs and finding the best ways to support them.
Quick facts
| Grant type | Career grant |
|---|---|
| Study type | NIH-funded research |
| Funding institution | Yale University NIH-funded |
| Lab location | 1 site (New Haven, United States) |
| Project start | September 30, 2024 |
| Project end | August 31, 2029 |
| Funding year | 2024 |
| Award (this year) | $161,151 |
| NIH project number | 1K01DA061692-01A1 |
| Project ID | NIH-11085528 on NIH RePORTER |
Who could benefit from this research
✓Could help
Ideal candidates for this research are individuals who use drugs and are currently on probation in Eastern Europe.
✕Less likely to help
Patients who are not on probation or do not use drugs may not benefit from this research.
What this research studies
This research focuses on developing effective strategies for implementing medications that help prevent HIV among individuals using drugs who are on probation in Eastern Europe. The project aims to enhance the skills of a sociologist in understanding and addressing the social factors that contribute to HIV risk in this population. By utilizing a combination of qualitative and quantitative research methods, the study will explore how to better engage and treat these individuals through a screening-engagement-treatment strategy. The research will take place in Georgia and Moldova, aiming to adapt interventions to the unique social and epidemiological contexts of these regions.
Why it matters
Potential benefit: If successful, this research could lead to improved HIV prevention strategies for drug users, ultimately reducing the incidence of HIV in this vulnerable population.
How similar studies have gone: Previous research has shown that tailored interventions for drug users can be effective in reducing HIV risk, suggesting that this approach may also yield positive results.
Where this research is happening
-
Yale University
New Haven, United States Active
Researchers
- Principal investigator: Azbel, Lyuba — Yale University
- Study coordinator: Azbel, Lyuba
Related research
Other NIH-funded projects on the same topics.
-
Integrating HIV prevention into opioid-use care to protect patients
A multi-institution team will find practical ways to weave HIV prevention like screening and PrEP into care settings where people with opioid use disorder already receive help.
-
Improving HIV Prevention for People with Opioid Use Disorder
This project aims to connect people with opioid use disorder to important HIV prevention services in places where they already receive care.
-
A new community approach to treat opioid use disorder and prevent HIV.
This study is looking at a new way to help people with opioid use disorder and prevent HIV by bringing care right into the community, using friendly nurses and outreach workers to support those at high risk with medication and services that can really make a difference in their health.
-
Integrating HIV prevention services into care for people with opioid use disorder
This study is looking at how to make it easier for people with opioid use disorder to get HIV prevention services, like testing and medication, by bringing these services into places they already visit for healthcare, like emergency rooms and clinics.
-
Systems analysis to improve opioid use disorder care after jail release (SAIA-MOUD)
A program to help people with opioid use disorder get better, faster, and safer care after they leave jail.
-
Precise epigenetic drugs for opioid addiction
A tiny, targeted drug approach is being developed to help people with opioid use disorder by rewriting the epigenetic signals in the brain to reduce cravings and relapse risk.
About this research
- This is an active NIH-funded research project — typically early-stage science, not a clinical trial accepting patient enrollment.
- Some NIH-funded labs run parallel clinical studies or seek volunteers for related work. To check, contact the principal investigator or institution listed above.
- For full project details, budget, and progress reports, visit the official NIH RePORTER page.